IR call - Acquisition of Bioverativ Inc.
Sanofi will acquire Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders. Sanofi hosted a conference call & webcast on the acquisition for the financial community.
(14h00 CET / 8:00am ET)